Patanjali aiming at ₹25,000 cr in sales this fiscal: Ramdev
Patanjali Ayurved Ltd will cross ₹20,000-25,000 crore in sales this financial year, said Baba Ramdev, the yoga guru who founded the fast-moving consumer goods (FMCG) firm.
In the year ending March 31, the company’s overall turnover stood at ₹10,561 crore, of which Patanjali Ayurved alone accounted for ₹9,346 crore and Divya Pharmacy ₹870 crore, said Ramdev.
While Patanjali sells products like soaps, toothpaste, hair oil, amla juice, atta, biscuits and noodles, Divya Pharmacy makes and sells Ayurvedic medicines.
In the next one or two years, Patanjali will become India’s largest “swadeshi” (local) brand, Ramdev claimed. “Turnover figures will force MNCS to go for kapalbhati (a breathing exercise). Let’s end their monopoly...,” he said at a press conference in New Delhi on Thursday.
He added Patanjali will give moksh (freedom from the cycle of birth and death) to MNCS in the Indian market in the next five years.
Patanjali has seen a meteoric rise in the last two to three years. From ₹446 crore in 2011-12, its revenue rose to ₹2,006 crore in 2014-15, and around ₹5,000 crore in the year ended March 31, 2016.
While most listed companies are yet to file annual results for the year to March 31, 2017, Nestle India Ltd, which follows the calendar year, reported revenue of ₹9,223.80 crore in year to December 31, 2016.
In year to March 31, 2016, Colgate-palmolive (India) Ltd’s revenue stood at ₹4,162.29 crore while GSK Consumer Healthcare Ltd clocked ₹4,308.72 crore. Hindustan Unilever Ltd saw its revenue touch ₹31,987.17 crore and ITC Ltd stood at ₹36,837.39 crore.
Patanjali has, in the past year, more than doubled its profit, said Ramdev, adding the company will use all the profit for charity.